| Chemical & Physical Properties | |
|---|---|
| CAS Number | 571189-51-0 |
| Catalog No. | 2A-3185010 |
| Chinese Name | 6-乙酰基-8-环戊基-5-甲基-2-((5-(4-甲基哌嗪-1-基)吡啶-2-基)氨基)吡啶并[2,3-d]嘧啶-7(8H)-酮(帕布昔利布杂质) |
| Molecular Formula | C25H31O2N7 |
| Molecular Weight | 461.57 |
| Storage Condition | 2-8°C, protect from light |
| Application | N-methylpaxiximab is an impurity of paxiximab (HY-50767). Palbociclib (PD 0332991) is an orally active, selective CDK4 and CDK6 inhibitor. |
| PubChem ID | 8035919 |
| MDL Number | MFCD34646162 |
| SMILES | CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(C)CC4)cn3)nc2n(C2CCCC2)c1=O |
| InChI | InChI=1S/C25H31N7O2/c1-16-20-15-27-25(28-21-9-8-19(14-26-21)31-12-10-30(3)11-13-31)29-23(20)32(18-6-4-5-7-18)24(34)22(16)17(2)33/h8-9,14-15,18H,4-7,10-13H2,1-3H3,(H,26,27,28,29) |
| InChI Key | PBSZUBKCQUPZFE-UHFFFAOYSA-N |
| Transport Info | Product name: 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)amino)pyrido[23-d]pyrimidin-7(8H)-one (palbociclib impurity) |
| Related Products in Analytical Standards | ||
|---|---|---|
| Palbociclib Impurity N-Oxide | 2174002-29-8 | 2A-3184883 |
| Palbociclib impurity 4 | 2A-3184885 | 2A-3184885 |
| Eletriptan Impurity 14 | 6163-63-9 | 2A-3184886 |
| Atorvastatin 10-Trans (Atorvastatin Impurity AT10) | 131275-93-9 | 2A-3184998 |
| Palbociclib impurity 33 | 1974279-40-7 | 2A-3185009 |
| Palbociclib Impurity I | 2172256-78-7 | 2A-3185013 |
| Tedizolid Impurity 3 | 1835340-19-6 | 2A-3185018 |
| Tedizolid Impurity 34 | 2095200-69-2 | 2A-0202146 |
| vildagliptin Impurity E | 1789703-37-2 | 2A-3185039 |
| Levosimendan impurity 6/Acetamide,N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-, (R)- | 39052-02-1 | 2A-3185042 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS